JP2023524603A5 - - Google Patents
Info
- Publication number
- JP2023524603A5 JP2023524603A5 JP2023502028A JP2023502028A JP2023524603A5 JP 2023524603 A5 JP2023524603 A5 JP 2023524603A5 JP 2023502028 A JP2023502028 A JP 2023502028A JP 2023502028 A JP2023502028 A JP 2023502028A JP 2023524603 A5 JP2023524603 A5 JP 2023524603A5
- Authority
- JP
- Japan
- Prior art keywords
- lys
- aib
- ala
- ser
- deletion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062994721P | 2020-03-25 | 2020-03-25 | |
| US62/994,721 | 2020-03-25 | ||
| PCT/JP2021/014422 WO2021193983A2 (en) | 2020-03-25 | 2021-03-25 | Qw dosing of gip receptor agonist peptide compounds and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023524603A JP2023524603A (ja) | 2023-06-12 |
| JP2023524603A5 true JP2023524603A5 (enExample) | 2024-04-04 |
Family
ID=75674909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023502028A Pending JP2023524603A (ja) | 2020-03-25 | 2021-03-25 | Ｇｉｆ受容体アゴニストペプチド化合物及びその使用 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20230143604A1 (enExample) |
| EP (1) | EP4126920A2 (enExample) |
| JP (1) | JP2023524603A (enExample) |
| KR (1) | KR20220157409A (enExample) |
| CN (1) | CN115916812A (enExample) |
| AR (1) | AR121649A1 (enExample) |
| AU (1) | AU2021243671A1 (enExample) |
| BR (1) | BR112022019110A2 (enExample) |
| CA (1) | CA3172241A1 (enExample) |
| CL (1) | CL2022002597A1 (enExample) |
| CO (1) | CO2022014960A2 (enExample) |
| EC (1) | ECSP22074715A (enExample) |
| IL (1) | IL296219A (enExample) |
| MX (1) | MX2022011729A (enExample) |
| PE (1) | PE20221727A1 (enExample) |
| PH (1) | PH12022552561A1 (enExample) |
| TW (1) | TW202202517A (enExample) |
| WO (1) | WO2021193983A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024525843A (ja) * | 2021-07-16 | 2024-07-12 | ぺプ２タンゴ セラピューティクス インコーポレイテッド | マルチアゴニストペプチドを含む組成物並びに製造及び使用方法 |
| WO2023139106A2 (en) * | 2022-01-18 | 2023-07-27 | Novo Nordisk A/S | Long-acting gipr antagonists |
| WO2025154020A1 (en) * | 2024-01-19 | 2025-07-24 | Takeda Pharmaceutical Company Limited | Improved gip receptor agonist peptide compounds and uses thereof |
| WO2025154021A1 (en) * | 2024-01-19 | 2025-07-24 | Takeda Pharmaceutical Company Limited | Improved gip receptor agonist peptide compounds and uses thereof |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1072649C (zh) | 1995-09-13 | 2001-10-10 | 武田药品工业株式会社 | 苯并氧杂吖庚因化合物,其生产方法和用途 |
| EP1302462A4 (en) | 2000-07-17 | 2007-07-18 | Takeda Pharmaceutical | SULFONATE DERIVATIVES, PROCESS FOR PRODUCTION AND USE THEREOF |
| BR0315815A (pt) | 2002-11-01 | 2005-09-13 | Takeda Pharmaceutical | Agentes para prevenir ou tratar neuropatia, para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor, neuroprotetor e farmacêutico, composto, métodos para prevenir ou tratar neuropatia e para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor para proteger um nervo em um mamìfero e para produzir um composto e uso de um composto |
| AU2003277576A1 (en) | 2002-11-08 | 2004-06-07 | Takeda Pharmaceutical Company Limited | Receptor function controlling agent |
| US20070004736A1 (en) | 2002-11-22 | 2007-01-04 | Keiji Kubo | Imidazole derivative, process for producing the same, and use |
| US7820837B2 (en) | 2003-05-30 | 2010-10-26 | Takeda Pharmaceutical Company Limited | Condensed ring compound |
| EP1669352A4 (en) | 2003-09-30 | 2008-12-17 | Takeda Pharmaceutical | THIAZOLINE DERIVATIVE AND ITS USE |
| WO2005058823A1 (ja) | 2003-12-17 | 2005-06-30 | Takeda Pharmaceutical Company Limited | ウレア誘導体、その製造法及び用途 |
| US7456218B2 (en) | 2003-12-25 | 2008-11-25 | Takeda Pharmaceutical Company Limited | 3-(4-benzyloxyphenyl) propanoic acid derivatives |
| WO2005063725A1 (ja) | 2003-12-26 | 2005-07-14 | Takeda Pharmaceutical Company Limited | フェニルプロパン酸誘導体 |
| WO2005087710A1 (ja) | 2004-03-15 | 2005-09-22 | Takeda Pharmaceutical Company Limited | アミノフェニルプロパン酸誘導体 |
| JP4859665B2 (ja) | 2004-03-30 | 2012-01-25 | 武田薬品工業株式会社 | アルコキシフェニルプロパン酸誘導体 |
| TWI396686B (zh) | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
| US8263545B2 (en) * | 2005-02-11 | 2012-09-11 | Amylin Pharmaceuticals, Inc. | GIP analog and hybrid polypeptides with selectable properties |
| US8957070B2 (en) | 2005-04-20 | 2015-02-17 | Takeda Pharmaceutical Company Limited | Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity |
| WO2006121904A1 (en) * | 2005-05-06 | 2006-11-16 | Bayer Pharmaceuticals Corporation | Glucose-dependent insulinotropic polypeptide (gip) receptor agonists and their pharmacological methods of use |
| EP1916234B1 (en) | 2005-07-29 | 2014-11-12 | Takeda Pharmaceutical Company Limited | Cyclopropanecarboxylic acid compound |
| US20090054435A1 (en) | 2005-07-29 | 2009-02-26 | Hiroshi Imoto | Phenoxyalkanoic Acid Compound |
| JP4094660B1 (ja) | 2005-08-10 | 2008-06-04 | 武田薬品工業株式会社 | 糖尿病治療剤 |
| JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| AU2007265966B2 (en) | 2006-06-27 | 2012-05-17 | Takeda Pharmaceutical Company Limited | Fused cyclic compounds |
| JP5399244B2 (ja) * | 2006-08-17 | 2014-01-29 | アミリン・ファーマシューティカルズ，リミテッド・ライアビリティ・カンパニー | 選択可能な特性を持つｄｐｐ−ｉｖ耐性ｇｉｐハイブリッドポリペプチド |
| EP2298772A1 (en) | 2006-10-18 | 2011-03-23 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compounds |
| CN101573357B (zh) | 2006-10-19 | 2013-01-23 | 武田药品工业株式会社 | 吲哚化合物 |
| WO2008093639A1 (ja) | 2007-01-29 | 2008-08-07 | Takeda Pharmaceutical Company Limited | ピラゾール化合物 |
| AU2008215490A1 (en) | 2007-02-09 | 2008-08-21 | Takeda Pharmaceutical Company Limited | Fused ring compounds as partial agonists of PPAR-gamma |
| JPWO2008136428A1 (ja) | 2007-04-27 | 2010-07-29 | 武田薬品工業株式会社 | 含窒素５員複素環化合物 |
| EP2157859A4 (en) | 2007-06-19 | 2011-01-12 | Takeda Pharmaceutical | INDAZOL COMPOUNDS FOR THE ACTIVATION OF GLUCCOKINASE |
| KR20130133103A (ko) * | 2008-08-07 | 2013-12-05 | 입센 파마 에스.에이.에스 | Ｎ-말단이 변형된 포도당 의존적인 인슐린 분비 자극성 폴리펩타이드(ｇｉｐ)의 유사체 |
| WO2010016936A1 (en) * | 2008-08-07 | 2010-02-11 | Ipsen Pharma S.A.S. | Pharmaceutical compositions of analogues of glucose-dependent insulinotropic polypeptide |
| JOP20190211A1 (ar) * | 2017-03-31 | 2019-09-15 | Takeda Pharmaceuticals Co | ببتيد منشط لمستقبل gip |
| IL296592A (en) * | 2020-03-25 | 2022-11-01 | Takeda Pharmaceuticals Co | Qd dosing of gip receptor agonist peptide compounds and uses thereof |
-
2021
- 2021-03-25 IL IL296219A patent/IL296219A/en unknown
- 2021-03-25 PE PE2022002091A patent/PE20221727A1/es unknown
- 2021-03-25 EP EP21721645.6A patent/EP4126920A2/en active Pending
- 2021-03-25 PH PH1/2022/552561A patent/PH12022552561A1/en unknown
- 2021-03-25 WO PCT/JP2021/014422 patent/WO2021193983A2/en not_active Ceased
- 2021-03-25 AU AU2021243671A patent/AU2021243671A1/en active Pending
- 2021-03-25 CA CA3172241A patent/CA3172241A1/en active Pending
- 2021-03-25 BR BR112022019110A patent/BR112022019110A2/pt unknown
- 2021-03-25 AR ARP210100729A patent/AR121649A1/es unknown
- 2021-03-25 MX MX2022011729A patent/MX2022011729A/es unknown
- 2021-03-25 KR KR1020227034445A patent/KR20220157409A/ko not_active Ceased
- 2021-03-25 JP JP2023502028A patent/JP2023524603A/ja active Pending
- 2021-03-25 TW TW110110875A patent/TW202202517A/zh unknown
- 2021-03-25 CN CN202180023693.4A patent/CN115916812A/zh active Pending
- 2021-03-25 US US17/914,013 patent/US20230143604A1/en active Pending
-
2022
- 2022-09-23 EC ECSENADI202274715A patent/ECSP22074715A/es unknown
- 2022-09-23 CL CL2022002597A patent/CL2022002597A1/es unknown
- 2022-10-20 CO CONC2022/0014960A patent/CO2022014960A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023519446A5 (enExample) | ||
| JP2022500483A5 (enExample) | ||
| JP2023012547A5 (enExample) | ||
| JP6814891B2 (ja) | ベンズイミダゾール誘導体の酸付加塩 | |
| TW200840571A (en) | Piperidine derivatives and methods of use thereof | |
| ES2966644T3 (es) | Fluorofenil beta-hidroxietilaminas y su uso en el tratamiento de la hiperglucemia | |
| JP4477097B2 (ja) | 中枢神経系障害の治療のための（２ｓ）−（４ｅ）−ｎ−メチル−５−［３−（５−イソプロポキシピリジン）イル］−４−ペンテン−２−アミンの多形形態 | |
| WO2022114164A1 (ja) | ヘテロアリールカルボキシアミド化合物 | |
| MX2011010448A (es) | Profarmacos de opioides novedosos de amino acidos y peptidos enlazados a acido dicarboxilico y usos de los mismos. | |
| CN108368110A (zh) | 用于激酶调节的化合物和方法以及其适应症 | |
| IL269581B2 (en) | Gip receptor activating peptide | |
| US12084431B2 (en) | Pharmaceutical salts of pyrimidine derivatives and method of treating disorders | |
| TW201930286A (zh) | 側氧哌嗪衍生物 | |
| WO2024149080A1 (zh) | 用作glp-1受体激动剂的4-烷氧基苯并咪唑-6-羧酸衍生物 | |
| CN101426500A (zh) | 治疗糖尿病和肥胖症的二肽基肽酶iv抑制剂和cb1受体拮抗剂的药物组合物 | |
| TW202102473A (zh) | 適用於治療高血糖症的雜環基（苯基）甲醇化合物 | |
| CN102497863A (zh) | 具有Aurora A选择性抑制作用的新型氨基吡啶衍生物 | |
| JP5924453B2 (ja) | 二環式含窒素芳香族ヘテロ環アミド化合物 | |
| WO2024140657A9 (zh) | 取代苯酚衍生物及其用途 | |
| KR100753005B1 (ko) | 1,5-벤조디아제핀 유도체 칼슘염 및 그의 제조법 및 이화합물을 유효 성분으로 하는 의약 | |
| TW202227455A (zh) | 異喹啉衍生物的無定形形式 | |
| CN112759587B (zh) | 3-(二甲氨基甲基)哌啶-4-醇类衍生物及其制备方法和药物用途 | |
| AU2014347065B2 (en) | 4-{4-[(1 E)-4-(2,9-diazaspiro[5.5]undec-2-yl)but-1 -en-1 -yl]-2-methylbenzyl}-5-(propan-2-yl)-1 H-pyrazol-3-yl beta-D- glucopyranoside acetate | |
| TWI374880B (en) | A pharmaceutically acceptable salt and solvate of n-[3-[[[2-[(2,3-dihydro-2-oxo-1h-indol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]-2-pyridinyl]-n-methylmethanesulfonamide and uses thereof | |
| KR20210087493A (ko) | 치환된-퀴녹살린-유형 브리지된-피페리딘 화합물의 다형체 형태 |